- Home
- CTM vs RPTX Comparison
CTM vs RPTX Comparison
Compare CTM & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTM | RPTX |
|---|---|---|
| Founded | 2019 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.0M | 92.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CTM | RPTX |
|---|---|---|
| Price | $1.16 | $2.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.00 | ★ $3.50 |
| AVG Volume (30 Days) | ★ 2.0M | 1.2M |
| Earning Date | 11-07-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $50,606,863.00 | $11,870,000.00 |
| Revenue This Year | $23.00 | N/A |
| Revenue Next Year | $11.91 | $9.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.09 | N/A |
| 52 Week Low | $0.26 | $0.89 |
| 52 Week High | $2.83 | $4.07 |
Technical Indicators
Market Signals| Indicator | CTM | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.64 | 60.62 |
| Support Level | $1.00 | $2.11 |
| Resistance Level | $1.07 | $2.24 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 92.11 | 40.91 |
Price Performance
Historical ComparisonAbout CTM Castellum Inc.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.